Sidra inks research, education, children's health agreement with Great Ormond Street Hospital
Doha
Sidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), one of the world's leading paediatric hospitals.
The agreement focuses on collaboration across key areas of clinical service, research, and education in children's health.
The MoU was signed by Dr. Iyabo Tinubu-Karch, chief executive officer of Sidra Medicine, and Matthew Shaw, chief executive officer of GOSH, in the presence of Duncan Hill, the British Deputy Ambassador to Qatar.
The partnership outlines a multi-year framework aimed at advancing treatment pathways for rare paediatric diseases, including the development and application of gene therapies. It will also enhance joint capabilities in clinical trial design and implementation, helping to drive progress in personalised paediatric medicine.
Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine, said: 'Our MoU with Great Ormond Street Hospital reflects our forward-looking vision to integrate global expertise into localised care models. With GOSH, we are building a knowledge bridge that will enhance clinical practice and drive the next wave of paediatric innovation with measurable impact on patient care.'
The alliance will create a coordinated referral system to facilitate timely access to advanced laboratory testing, ensuring specialized care for children with complex conditions, including genetic disorders and rare diseases. This streamlined approach will also improve diagnostic efficiency and support the creation of personalized treatment plans.
Matthew Shaw, CEO of GOSH, said: 'What we are building together with Sidra Medicine will strengthen paediatric health systems for the future by leveraging expertise in clinical care, research, data and innovation, and education and training. By combining our expertise, we are not only supporting current clinicians but also laying the foundation for a more connected, resilient, and equitable model of global child health.'
Under the agreement, both institutions will roll out education and skills exchange initiatives to support the next generation of healthcare professionals. This includes pathways for physicians, nurses, allied health staff, through international fellowships, observerships, and training programmes.
Prof. Ibrahim Janahi, chief medical officer at Sidra Medicine, said: 'Sidra Medicine's partnership with GOSH creates valuable opportunities for training, fellowships, and medical education, bringing together professionals from diverse backgrounds and specialties. Our joint efforts will foster innovation, strengthen clinical skills as well as our medical education programmes.
'This will help us develop a more knowledgeable and future-ready paediatric healthcare workforce, which will also ultimately improve how we provide paediatric care services.'
The MoU with GOSH also aligns with Sidra Medicine's Clinical Trials Programme, which focuses on the development of effective treatments for paediatric rare diseases.
Prof. Khalid Fakhro, chief research officer at Sidra Medicine, said: 'Sidra Medicine's unique genetic data on Arab populations, combined with GOSH's advanced secure data environment, world-class clinical and research expertise, creates a powerful opportunity to develop region-specific diagnostic tools and clinical trials. By partnering with GOSH, Sidra Medicine aims to accelerate access to state-of-the-art therapies and expertise necessary to improve outcomes for all our patients.'
By aligning clinical pathways, innovation, education, and research and through knowledge and skills exchange, Sidra Medicine and GOSH are laying the foundation for a future where children everywhere have access to more precise, effective, and inclusive healthcare solutions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Foundation
a day ago
- Qatar Foundation
The Science of Eating Right: How Precision Nutrition Works
Image source: Lightspring, via Shutterstock Dr. Annalisa Terranegra of QF's Sidra Medicine uncovers how precision nutrition is changing the way we approach health and wellness Related Stories
Qatar Tribune
4 days ago
- Qatar Tribune
The View Hospital becomes first in Qatar to offer 3D CT Gastric Volume Study for bariatric patients
Tribune News Network Doha The View Hospital, in affiliation with Cedars-Sinai, has become the first hospital in Qatar to offer the 3D CT Gastric Volume Study, an advanced diagnostic imaging service that gives physicians a clearer view of post-surgical anatomy in bariatric patients. The launch of the service marks a milestone not only for the hospital but for the country's evolving landscape of precision medicine. Designed specifically for individuals who have undergone bariatric procedures, the 3D CT Gastric Volume Study delivers highly detailed, three-dimensional images that accurately assess the size and shape of the remaining stomach. The technology helps clinicians detect structural abnormalities, track patient progress, and anticipate potential complications, all with exceptional accuracy and speed. 'For many patients, bariatric surgery is a turning point in their health journey,' said Dr Jassim Fakhro, senior consultant in Metabolic and Bariatric Surgery and Medical Director of Qatari Physicians at The View Hospital. 'But it doesn't end in the operating room. Ongoing monitoring is key, and with this technology, we can now offer unmatched insight and support as patients work toward a healthier future.' This imaging advancement couldn't come at a more crucial time. As rates of obesity and metabolic disease rise across the region, bariatric surgery has emerged as a powerful tool for intervention. But surgery alone isn't enough - what follows is a complex physiological transition that demands thoughtful, individualized follow-up care. That's where the 3D CT Gastric Volume Study makes its impact. By visualising the internal anatomy in such detail, physicians can make data-driven decisions tailored to each patient's unique post-surgical profile. Whether it's adjusting dietary recommendations, identifying mechanical issues, or flagging early signs of nutritional compromise, this diagnostic innovation offers a more complete picture and a more proactive path forward. Moreover, this technology plays a pivotal role in planning revisional bariatric surgeries, particularly in cases of weight regain or severe GERD (gastroesophageal reflux disease) after the initial procedure. The precise anatomical data provided by the 3D imaging enables surgeons to better evaluate the structural causes behind such complications and tailor surgical interventions, accordingly, improving outcomes and patient safety. 'At The View Hospital, we are committed to healthcare innovation and advancing academic care,' said Dr Fatih Mehmet Gul, CEO of The View Hospital. 'The launch of Qatar's first 3D CT Gastric Volume Study for bariatric patients reflects our medical expertise and dedication to providing precise, personalized treatment through cutting-edge technologies.' With this latest addition, The View Hospital further strengthens its position as a leader in advanced, patient-centered care. By combining innovative technology with a deep commitment to personalized medicine, the hospital continues to raise the bar for what modern healthcare should look likein Qatar and across the region.
Qatar Foundation
09-07-2025
- Qatar Foundation
Is Artificial Intelligence undermining journalism – and how should journalism respond?
A professor at a Qatar Foundation partner university warns of the "blind power" of AI – and its potential consequences for human knowledge Related Stories Story 3 min read QF's Mehnaty and Al Meydan programs help bridge the gap between classroom learning and the workplace Story 137 British-based graduates of QF's schools and universities are making their mark in fields ranging from AI and medicine to policy and sustainability Story 5 min read As QF continues building the region's future healthcare leaders, one medical student's research success highlights the power of accessible world-class education
